companydata.dkGK PHARMA ApS: Financial statements 2012
CVR: 81267316
GK PHARMA ApS (CVR 81267316) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 7,684,705 and a net result of DKK 29,961. The profit margin was 0.4%. Equity amounted to DKK 258,095. The solvency ratio was 9.4%.
- Revenue
- 7,684,705 kr.
- Gross Profit
- 2,444,997 kr.
- Profit/Loss
- 29,961 kr.
- Equity
- 258,095 kr.
- Total Assets
- 2,732,617 kr.
How creditworthy is GK PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of August 1, 2012, Andrew John Reks Jacobsen has joined the board of directors of GK PHARMA ApS.
As of August 1, 2012, Klaus Groth has left the board of directors of GK PHARMA ApS.
As of August 1, 2012, Andrew John Reks Jacobsen is registered as director of GK PHARMA ApS.
As of August 1, 2012, Klaus Groth has stepped down as adm. dir. of GK PHARMA ApS.
About GK PHARMA ApS
GK PHARMA ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 1977. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Klaus Groth. The company is owned by Salvefabrikken ApS. The company has 10 employees. In 2025, the company reported a gross profit of DKK 5,931,212 and a net result of DKK 2,646,889 compared with DKK 954,244 the year before. Equity amounted to DKK 4,029,041.